Soquinolol
Code | Size | Price |
---|
TAR-T28829-1mg | 1mg | £188.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-5mg | 5mg | £352.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-10mg | 10mg | £496.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-25mg | 25mg | £760.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-50mg | 50mg | £1,018.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-100mg | 100mg | £1,348.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28829-500mg | 500mg | £2,633.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Soquinolol is a beta adrenergic receptor antagonist without any intrinsic sympathomimetic activity. Its localanaesthetic activity is very weak. Soquinolol also shows good enteral efficacy and long duration of action.
CAS:
61563-18-6
Formula:
C17H26N2O3
Molecular Weight:
306.406
Pathway:
Neuroscience|GPCR/G Protein
Purity:
0.98
SMILES:
CC(C)(C)NCC(O)COc1cccc2CN(CCc12)C=O
Target:
Adrenergic Receptor
References
1. Chen KH, Hsu WM, Lee SM. Differential effects of transforming growth factor-beta2 on corneal endothelial cell proliferation-A role of serum factors. Exp Eye Res. 2002 Jul;75(1):61-7. PubMed PMID: 12123637.
2. Gries J, Unger L, Einig H, Friedrich L, Hofmann HP, Kreiskott H, Lehmann HD, von Philipsborn G, Wuppermann D, Zimmermann F. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol]. Arzneimittelforschung. 1988 Sep;38(9):1271-9. German. PubMed PMID: 2906243.
3. Mydlo JH, Gerstein MI, Harris CF, Braverman AS. Immune function, mitogenicity, and angiogenic growth factor concentrations in lean and obese rodent sera: implications in obesity-related prostate tumor biology. Prostate Cancer Prostatic Dis. 2003;6(4):286-9. PubMed PMID: 14663468.
4. Zhang Q, Bratton GR, Agarwal RK, Calise D, Kugel G, Wan Y, Kumar AM. Lead-induced cell signaling cascades in GT1-7 cells. Brain Res Bull. 2003 Jul 15;61(2):207-17. PubMed PMID: 12832008.